Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial.
Saved in:
| Title: | Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 Trial. |
|---|---|
| Authors: | Gooderham, Melinda1 (AUTHOR) mgooderham@centrefordermatology.com, Bunick, Christopher G.2 (AUTHOR), Yu, JiaDe3 (AUTHOR), Maslin, Douglas4,5 (AUTHOR), Schneider, Shannon K. R.6 (AUTHOR), Østerdal, Marie Louise4 (AUTHOR), Søhoel, Anders4 (AUTHOR), Madsen, Daniel Elenius4 (AUTHOR), Eichenfield, Lawrence F.7 (AUTHOR) |
| Source: | Dermatology & Therapy. Jul2026, Vol. 16 Issue 7, p3275-3283. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-026-01767-1 |
